Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 12—December 2022
Research

Daily Rapid Antigen Exit Testing to Tailor University COVID-19 Isolation Policy

Rebecca EarnestComments to Author , Christine Chen, Chrispin Chaguza, Anne M. Hahn, Nathan D. Grubaugh1, Madeline S. Wilson1, and for the Yale COVID-19 Resulting and Isolation Team2
Author affiliations: Yale School of Public Health, New Haven, Connecticut, USA (R. Earnest, C. Chaguza, A.M. Hahn, N.D. Grubaugh); Yale Health, New Haven (C. Chen, M.S. Wilson); Yale University, New Haven (N.D. Grubaugh)

Main Article

Table 2

Event time ratios of the association between covariates in study of students in a university-managed isolation program, January 1–February 11, 2022*

Covariate Sample size ETR (95% CI) p value
Time since last negative test, d
<4† 155 NA NA
5–9 40 0.88 (0.77NA1.01) 0.065
>10
68
0.85 (0.75NA0.96)
0.008
Symptoms at diagnosis
N 104 NA Referent
Y
159
1.13 (1.02NA1.25)
0.016
Ct value at diagnosis
263
1 (0.99NA1)
0.378
Prior infection >90 d
N† 244 NA NA
Y
19
0.5 (0.33NA0.76)
0.001
No. dose/time since last dose
2 doses / >5 mo† 44 NA NA
2 doses / <5 mo 31 1.29 (0.97NA1.73) 0.083
3 doses
188
1.2 (1.04NA1.39)
0.012
Primary vaccine brand
Janssen/Johnson & Johnson† 24 NA NA
mRNA 239 1.21 (0.89NA1.65) 0.219

*N = 263 persons who were fully vaccinated with Pfizer-BioNTech (https://www.pfizer.com), Moderna (https://modernatx.com), or Janssen/Johnson & Johnson (https://jnj.com), did not additionally receive an international vaccine, and did not have a missing Ct value or symptom status. ETR >1 is associated with prolonged RAT positivity duration compared to the reference group. An ETR <1 is associated with a decreased RAT positivity duration. Ct, cycle threshold; Dx, diagnosis; ETR, event time ratio; mRNA, either of the mRNA vaccines from Pfizer or Moderna; NA, not applicable; RAT, rapid antigen test.

Main Article

1These authors contributed equally to this article.

2Members of the team are listed at the end of this article.

Page created: November 08, 2022
Page updated: November 21, 2022
Page reviewed: November 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external